Explore the full directors' dealings record of International Flavors & Fragrances INC, a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Chemicals & Materials sector, International Flavors & Fragrances INC has recorded 53 insider filings. Market capitalisation: €18.7bn. The latest transaction was filed on 2 June 2022 (Cession). Among the most active insiders: Herriott Simon. The full history is free.
0 of 0 declarations
International Flavors & Fragrances Inc. (IFF) is a U.S.-listed company traded on the NYSE (United States) and one of the best-known global suppliers of specialty ingredients for consumer products, food and beverage applications, beauty and personal care, household care, and health-related uses. The company traces its heritage back to 1889 through Polak & Schwarz in the Netherlands, while the modern IFF was formed in New York in 1958 through a merger with van Ameringen-Haebler. Its headquarters are in New York, underscoring its long-standing position as a U.S.-based global player in flavors, fragrances, and applied biosciences. IFF’s business model is built around several complementary platforms, now organized around Taste, Food Ingredients, Health & Biosciences, and Scent. This portfolio spans flavor systems for foods and beverages, functional ingredients that improve texture, taste, nutrition, and processing performance, bioscience solutions and enzymes used in industrial and consumer applications, and fragrance compounds and ingredients for fine fragrance, personal care, and home care products. The breadth of this mix gives IFF exposure to a wide range of end markets while keeping the core business centered on high-value, innovation-driven specialty ingredients. From a competitive standpoint, IFF operates in an industry with significant barriers to entry. Success depends on scientific expertise, formulation know-how, regulatory compliance, strong customer relationships, and the ability to co-develop tailored solutions. The company positions itself as a global innovation partner, combining science and creativity to help customers address changing consumer preferences, sustainability goals, and performance requirements. In practice, that means IFF competes less on commodity pricing and more on technical differentiation, application support, and long-term customer intimacy. Geographically, IFF has a broad international footprint across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. This global reach is strategically important because many of its customers are multinational consumer goods and food companies with worldwide supply chains. At the same time, the company remains exposed to foreign exchange movements, input-cost inflation, logistics disruptions, and regulatory differences across jurisdictions. Recent developments show a company still in the middle of a portfolio and profitability transformation. In 2025, IFF reported an expected divestiture of its soy crush, concentrates, and lecithin business, following earlier portfolio actions including the divestiture of Pharma Solutions. It also announced a strategic collaboration with BASF to accelerate next-generation enzyme and biomaterials innovation, reinforcing its technology-led positioning. In its first-quarter 2025 results, IFF highlighted a large goodwill impairment in Food Ingredients, and management’s guidance continued to reflect the impact of divestitures and foreign exchange. For investors, IFF remains a high-quality specialty ingredients franchise with global scale, but one that is actively reshaping its portfolio and financial profile.